Researchers at the George Washington University published findings from the world’s largest cohort study showing that hospitalized patients with moderate COVID-19 who were given aspirin early on in their treatment had a lower risk of dying compared to patients who were not given aspirin.
Aspirin may reduce death In hospitalized COVID-19 patients
March 24, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022